3 registrations that name black chokeberry as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 3 registrations
Status
All 3 registrations
RecruitingNCT05432362
ESAN II - Energy Sensing in Depression
No phase
Medical University of Graz
About 120 people
Started Feb 25, 2019
In plain words A study of black chokeberry in female participants 18 to 40, run by Medical University of Graz. It plans to enroll about 120 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists female participants 18 to 40; healthy volunteers accepted. Conditions: Immune System Tolerance; Depression; Obesity; Microbial Colonization; Diet, Healthy.
Socio-demographic criteria:
Gender: female
Age: 18-40 years
Confirmation of the study settings
17 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Aronia Juice; Placebo
Registered summary
The purpose of this study is to assess the effects of polyphenols from natural aronia juice on the immune system. Therefore, the study aims to distinguish the effects of natural juices that are rich in phytonutrients such as polyphenols and carotenoids in healthy and depressive subjects in order to use the known positive effects of these food sources in the therapeutic setting. The consumption of natural fruit juices that are rich in polyphenols and carotenoids mirror a model of vegetarian diet due to the increased micronutrient density derived from plant food. The full summary is on the listing.
Where, as registered
No US site; Austria (1).
RecruitingNCT06702696
Effect of Aronia Berry Consumption on Inflammatory Parameters
No phase
Amasya University
About 50 people
Started Nov 15, 2024
In plain words A study of black chokeberry in people 50 to 80, run by Amasya University. It plans to enroll about 50 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 50 to 80. Conditions: COPD (Chronic Obstructive Pulmonary Disease).
Aged 50-80 years
Diagnosed with COPD
Not following a vegetarian or vegan diet
Willing to consume the provided aronia berry (black chokeberry)
3 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Black chokeberry (Aronia melanocarpa); Placebo powder
Registered summary
The study will aim to evaluate the effects of consuming freeze-dried aronia berries as an adjunct to medical treatment in patients with chronic obstructive pulmonary disease (COPD), focusing on anti-inflammatory, respiratory, and biochemical parameters. It will be conducted at a research hospital in Istanbul, involving 50 participants aged 50-80 diagnosed with COPD. Participants will be randomly assigned to two groups: the aronia group (AG, n=25) and the placebo group (PG, n=25). The full summary is on the listing.
Where, as registered
No US site; Turkey (Türkiye) (1).
Not yet recruitingNCT07829523
Effect of Aronia Supplementation on the LPS-CD14-TLR2/4 Axis in Football Players
No phase
Hanna Dziewiecka
About 40 people
Starts Oct 10, 2026 (estimated)
In plain words A study of black chokeberry in male participants 16 to 35, run by Hanna Dziewiecka. It plans to enroll about 40 people and lists no sites yet.
Who it lists and where
Who the trial lists, as registered
Lists male participants 16 to 35; healthy volunteers accepted. Conditions: Exercise Training.
Male participants aged 16-35 years.
Regularly training football players.
Healthy and medically eligible to participate in the exercise testing.
Willingness to comply with the study procedures and pre-test instructions.
This randomized, double-blind, placebo-controlled trial will investigate the effects of 8-week Aronia melanocarpa supplementation on exercise-induced activation of the LPS-LBP-CD14-TLR2/TLR4 axis in trained male football players. Participants will be randomly assigned to receive either Aronia melanocarpa supplementation or placebo. Exercise testing will be performed before and after the 8-week intervention, with blood samples collected before, immediately after, and 1 hour after exercise. The full summary is on the listing.